StreetInsider.com News Articles

This biotech stock still Wolfe's top pick as multiple catalysts loomh

Mon, 31 Aug 2026 08:00:00 -0400

Wolfe Research raised its price target on a biotechnology company for the second time this year, calling it a top pick as it awaits several potential clinical catalysts over the next 12 months.

The brokerage reiterated an Outperform rating on Dianthus Therapeutics (NASDAQ: DNTH) and raised its price target to $141, up from $109, implying more than 33% upside from the last closing price. Analyst Andy Chen said he expects the stock to unlock value through its myasthenia gravis (MG) program, which he views as "a low-risk shot & potentially bigger upside on a readthrough from Biogen's litifilimab & Vor's MG

This biotech stock still Wolfe's top pick as multiple catalysts loomh

Mon, 31 Aug 2026 08:00:00 -0400

Wolfe Research raised its price target on a biotechnology company for the second time this year, calling it a top pick as it awaits several potential clinical catalysts over the next 12 months.

This biotech stock still Wolfe's top pick as multiple catalysts loomh

Mon, 31 Aug 2026 08:00:00 -0400

Wolfe Research raised its price target on a biotechnology company for the second time this year, calling it a top pick as it awaits several potential clinical catalysts over the next 12 months.

This biotech stock still Wolfe's top pick as multiple catalysts loomh

Mon, 31 Aug 2026 08:00:00 -0400

Wolfe Research raised its price target on a biotechnology company for the second time this year, calling it a top pick as it awaits several potential clinical catalysts over the next 12 months.

This biotech stock still Wolfe's top pick as multiple catalysts loomh

Mon, 31 Aug 2026 08:00:00 -0400

Wolfe Research raised its price target on a biotechnology company for the second time this year, calling it a top pick as it awaits several potential clinical catalysts over the next 12 months.

This biotech stock still Wolfe's top pick as multiple catalysts loomh

Mon, 31 Aug 2026 08:00:00 -0400

Wolfe Research raised its price target on a biotechnology company for the second time this year, calling it a top pick as it awaits several potential clinical catalysts over the next 12 months.

Form 4 Dianthus Therapeutics, For: Aug 19 Filed by: Read Simon

Wed, 19 Aug 2026 18:03:00 -0400

si-local-file:///var/storage/secattach/20260819/26951360.html

Form 4 Dianthus Therapeutics, For: Aug 19 Filed by: Read Simon

Wed, 19 Aug 2026 18:03:00 -0400

si-local-file:///var/storage/secattach/20260819/26951360.html

Form 4 Dianthus Therapeutics, For: Aug 13 Filed by: Veness Adam M

Fri, 14 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260814/26931491.html

Form 4 Dianthus Therapeutics, For: Aug 13 Filed by: Veness Adam M

Fri, 14 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260814/26931491.html

Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Sirenia Capital Management LP

Fri, 14 Aug 2026 08:33:00 -0400

si-local-file:///var/storage/secattach/20260814/26925195.html

Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Sirenia Capital Management LP

Fri, 14 Aug 2026 08:33:00 -0400

si-local-file:///var/storage/secattach/20260814/26925195.html

Form SCHEDULE 13G Dianthus Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP

Thu, 13 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260813/26920791.html

Form SCHEDULE 13G Dianthus Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP

Thu, 13 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260813/26920791.html

Form 4 Dianthus Therapeutics, For: Aug 10 Filed by: McGeorge Anne

Tue, 11 Aug 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260811/26907046.html

Form 4 Dianthus Therapeutics, For: Aug 10 Filed by: McGeorge Anne

Tue, 11 Aug 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260811/26907046.html

Form 4 Dianthus Therapeutics, For: Aug 10 Filed by: Read Simon

Tue, 11 Aug 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20260811/26906983.html

Form 4 Dianthus Therapeutics, For: Aug 10 Filed by: Read Simon

Tue, 11 Aug 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20260811/26906983.html

Form 4 Dianthus Therapeutics, For: Aug 07 Filed by: Veness Adam M

Tue, 11 Aug 2026 17:09:00 -0400

si-local-file:///var/storage/secattach/20260811/26906962.html

Form 4 Dianthus Therapeutics, For: Aug 07 Filed by: Veness Adam M

Tue, 11 Aug 2026 17:09:00 -0400

si-local-file:///var/storage/secattach/20260811/26906962.html

Form 144 Dianthus Therapeutics, Filed by: Veness Adam M

Mon, 10 Aug 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260810/26898852.html

Form 144 Dianthus Therapeutics, Filed by: Veness Adam M

Mon, 10 Aug 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260810/26898852.html

Form 144 Dianthus Therapeutics, Filed by: Read Simon

Mon, 10 Aug 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260810/26898606.html

Form 144 Dianthus Therapeutics, Filed by: Read Simon

Mon, 10 Aug 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260810/26898606.html

Form 144 Dianthus Therapeutics, Filed by: McGeorge Anne

Mon, 10 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260810/26898565.html